ConditionBones, joints & muscles
Mixed Connective Tissue Disease (MCTD)
Mixed connective tissue disease (MCTD) is a rare autoimmune disease that blends features of lupus, scleroderma and polymyositis, with high levels of an antibody called anti-U1 RNP. It usually begins with Raynaud's phenomenon (fingers turning white or blue in the cold), puffy swollen hands, joint pain and tiredness. Over time it can affect the muscles, esophagus, lungs and heart. There is no cure, but treatment controls symptoms, and regular lung and heart screening catches the serious complications early.
Also called: MCTD, Sharp syndrome, overlap connective tissue disease
At a glance
- What it is
- An overlap autoimmune disease with features of lupus, scleroderma and polymyositis.
- Who gets it
- Mostly women, usually starting between the ages of 15 and 40.
- Early signs
- Raynaud's phenomenon, swollen "sausage" fingers, joint pain, muscle aches and fatigue.
- Key test
- High levels of anti-U1 RNP antibodies with a speckled ANA pattern.
- Treatment
- Tailored to the organs involved: hydroxychloroquine, NSAIDs, steroids and immunosuppressants.
- Biggest risk
- Lung complications, especially pulmonary hypertension, so yearly screening is important.
When to get help
Call 911 or go to the ER
- Chest pain, severe breathlessness, fainting or coughing up blood
- A finger or toe that turns black, stays white and cold, or develops a painful open sore that is spreading
- Severe headache with fever and a stiff neck
See a doctor within a day or two
- Breathlessness on exertion that is getting worse, or new swelling of the ankles
- A dry cough lasting more than 3 weeks
- New muscle weakness, such as trouble climbing stairs or lifting your arms
- Difficulty swallowing with weight loss
Book a routine appointment
- Fingers that turn white or blue in the cold, with puffy hands and joint pain
- Ongoing fatigue, low fevers and aches that come and go
- Your yearly echocardiogram and lung function tests if you have MCTD
Usually safe to manage at home
- Mild Raynaud's attacks: warm the hands, wear gloves and layers, and avoid smoking
- Heartburn: smaller meals, no food within 3 hours of bed and raising the head of the bed
What MCTD is
In autoimmune diseases, the immune system attacks the body's own tissues. In MCTD, the immune system makes antibodies against a protein complex in cell nuclei called U1 small nuclear ribonucleoprotein (U1 RNP). People have a mix of features from three diseases:
- Lupus: rashes, joint pain, mouth ulcers, low blood counts, pleurisy
- Scleroderma: Raynaud's, swollen and tight finger skin, esophageal problems, lung scarring
- Polymyositis: muscle inflammation and weakness
Features of rheumatoid arthritis and Sjögren's syndrome can also occur. MCTD is one of the connective tissue disorders. Some experts consider it a distinct disease, while others see it as an overlap syndrome. Over years, some people's disease evolves to look more like lupus or scleroderma alone.
Symptoms
Early symptoms
- Raynaud's phenomenon: present in nearly everyone with MCTD and often the first sign, sometimes years before anything else. Fingers turn white, then blue, then red with cold or stress.
- Puffy, swollen hands and "sausage-like" fingers.
- Joint pain and swelling, usually in the hands, wrists and knees.
- Muscle aches, and sometimes true muscle weakness.
- Fatigue, low-grade fever and feeling generally unwell.
Later or organ-related symptoms
- Esophagus: heartburn and food sticking, from weak esophageal muscle. This is very common.
- Lungs: breathlessness and dry cough from interstitial lung disease, or pleurisy.
- Pulmonary arterial hypertension: high blood pressure in the lung arteries, causing breathlessness on exertion, fatigue, chest pain, fainting and ankle swelling.
- Skin: tightening of finger skin, rashes, hair thinning and finger ulcers.
- Heart: inflammation of the lining around the heart (pericarditis).
- Nerves: trigeminal neuralgia (sharp facial pain) and, less often, aseptic meningitis.
- Blood: low red cells, white cells or platelets.
- Kidney problems are less common than in lupus.
Causes and risk factors
The cause is unknown. As with other autoimmune diseases, a combination of genes (certain HLA types) and environmental triggers is thought to be involved. About 80% or more of patients are women. It is not contagious and is not usually passed directly from parent to child.
How MCTD is diagnosed
There is no single definitive test, and several sets of diagnostic criteria exist. Diagnosis rests on:
- Symptoms and exam: especially Raynaud's, swollen hands, arthritis and muscle findings.
- Antinuclear antibody (ANA): strongly positive, usually with a speckled pattern.
- Anti-U1 RNP antibodies: high levels are required for the diagnosis. Antibodies typical of lupus (anti-dsDNA, anti-Sm) and scleroderma (anti-Scl-70, anticentromere) are usually absent.
- Muscle tests: creatine kinase (CK) blood test, and sometimes EMG, MRI or muscle biopsy.
- Organ screening: pulmonary function tests, a high-resolution chest CT, an echocardiogram to estimate lung artery pressure, and sometimes a right heart catheterization.
- Other tests: blood count, kidney function, urine tests and nailfold capillaroscopy (a magnified look at the small vessels at the nail base).
MCTD vs lupus and scleroderma
| MCTD | Lupus | Scleroderma | |
|---|---|---|---|
| Key antibody | High anti-U1 RNP | Anti-dsDNA, anti-Sm | Anti-Scl-70, anticentromere, anti-RNA polymerase III |
| Raynaud's | Nearly always | Sometimes | Nearly always |
| Swollen hands | Very common | Uncommon | Common early |
| Serious kidney disease | Uncommon | Common | Kidney crisis possible |
| Main lung risk | Pulmonary hypertension, lung scarring | Pleurisy | Lung scarring, pulmonary hypertension |
Treatment
Treatment depends on which features are active. A rheumatologist leads care, often with lung, heart and skin specialists.
- Joint pain and fatigue: NSAIDs if safe for you, and hydroxychloroquine, which is commonly used long-term.
- Inflammation flares, myositis and serositis: corticosteroids such as prednisone, ideally at the lowest effective dose for the shortest time.
- Steroid-sparing drugs: methotrexate, azathioprine or mycophenolate.
- Lung scarring: mycophenolate, and cyclophosphamide or rituximab for severe disease.
- Pulmonary arterial hypertension: specialist drugs that widen the lung arteries, along with immunosuppression in some people.
- Raynaud's: keeping warm, stopping smoking and avoiding decongestants, plus calcium channel blockers such as nifedipine if needed.
- Heartburn and swallowing problems: acid-suppressing medicines and lifestyle measures.
Living with MCTD
- Keep warm and protect your hands from cold and injury.
- Do not smoke, because smoking worsens Raynaud's and lung disease.
- Stay active with regular exercise to maintain muscle strength and joint movement.
- Keep up with vaccines. Ask before live vaccines if you take immunosuppressants.
- Plan pregnancies with your rheumatologist, because some medicines must be stopped beforehand and pregnancy needs closer monitoring.
Outlook
The course varies. Many people have mild disease that responds well to treatment, sometimes with long periods of remission. Others develop lung involvement. Pulmonary hypertension is the leading cause of death in MCTD, which is why yearly screening with an echocardiogram and lung function tests is recommended even without symptoms. With modern treatment and monitoring, most people live for many years with the condition.
Frequently asked questions
What are the first signs of mixed connective tissue disease?
The first sign is usually Raynaud's phenomenon, with fingers turning white or blue in the cold. Puffy, swollen hands, joint pain, muscle aches, fatigue and low-grade fevers commonly follow. These early symptoms can come on gradually over months to years.
What is the life expectancy with MCTD?
Most people with MCTD live for many years, and many have a near-normal life span, especially with mild disease. Outlook depends mainly on lung and heart involvement. Pulmonary hypertension is the most serious complication, so regular screening and early treatment are important.
Is MCTD the same as lupus?
No. MCTD shares some features with lupus, such as joint pain and rashes, but also includes features of scleroderma and myositis. It is defined by high anti-U1 RNP antibodies, while serious kidney disease, common in lupus, is less common in MCTD. Over time some people's MCTD evolves into lupus.
What does a positive anti-U1 RNP test mean?
Anti-U1 RNP antibodies are found at high levels in almost everyone with MCTD and are required for the diagnosis. They also occur in some people with lupus and other autoimmune diseases. A positive result is interpreted together with symptoms and other tests by a rheumatologist.
Can mixed connective tissue disease go into remission?
Yes. Some people have long periods with few or no symptoms, especially with treatment. Others have flares, and the disease can change over time to resemble lupus or scleroderma more closely. Regular follow-up helps adjust treatment as the disease changes.
Sources
This guide was written from current patient and clinical guidance, including:
- American College of Rheumatology: Mixed Connective Tissue Disease patient fact sheet
- NIH Genetic and Rare Diseases Information Center: Mixed connective tissue disease
- NCBI StatPearls: Mixed Connective Tissue Disease
- Johns Hopkins Lupus and Rheumatology Centers: Mixed connective tissue disease
- MedlinePlus: Mixed connective tissue disease